![Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia - ScienceDirect Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920319662-gr4.jpg)
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia - ScienceDirect
![Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia - ScienceDirect Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920319662-gr1.jpg)
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia - ScienceDirect
![Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy - Venugopal - 2021 - Cancer - Wiley Online Library Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy - Venugopal - 2021 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/708ffd30-eb7f-4f09-a335-4f267f3e45e3/cncr33675-fig-0002-m.jpg)
Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy - Venugopal - 2021 - Cancer - Wiley Online Library
![TP53 alterations of hormone-naïve prostate cancer in the Chinese population | Prostate Cancer and Prostatic Diseases TP53 alterations of hormone-naïve prostate cancer in the Chinese population | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-020-00302-3/MediaObjects/41391_2020_302_Fig1_HTML.png)